AJP - Heart and Circulatory Physiology, Vol 248, Issue 1 33-H39, Copyright © 1985 by American Physiological Society

ARTICLES

Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons

G. T. Wetzel and J. H. Brown

Acetylcholine can be released from parasympathetic nerve endings in rat atria by 57 mM K+ depolarization or by electrical field stimulation. We have studied the presynaptic modulation of [3H]acetylcholine release from superfused rat atria prelabeled with [3H]choline. Exogenous acetylcholine and the specific muscarinic agonist oxotremorine inhibit the stimulation-induced overflow of [3H]acetylcholine into the superfusion medium. The half-maximal inhibitory concentration (IC50) of oxotremorine is 0.3 microM. The cholinesterase inhibitor neostigmine also decreases K+-stimulated [3H]acetylcholine overflow, whereas the muscarinic antagonist atropine enhances the overflow of [3H]acetylcholine. These data suggest that acetylcholine release in atria is modulated through negative feedback by the endogenous transmitter. The sympathetic adrenergic neurotransmitter norepinephrine and the neurohormone epinephrine also inhibit the overflow of [3H]acetylcholine by approximately 60%. The IC50 values for the inhibitory effects of these catecholamines are 6.3 and 2.2 microM, respectively. The inhibitory effect of norepinephrine is blocked by the alpha-adrenergic receptor antagonist yohimbine but not by the beta-adrenergic receptor antagonist propranolol. We suggest that presynaptic muscarinic and alpha-adrenergic receptors participate in the physiological and pharmacological control of cardiac parasympathetic activity.

This article has been cited by other articles:

				D. C. Parrish, E. N. Alston, H. Rohrer, S. M. Hermes, S. A. Aicher, P. Nkadi, W. R. Woodward, J. Stubbusch, R. T. Gardner, and B. A. Habecker Absence of gp130 in dopamine {beta}-hydroxylase-expressing neurons leads to autonomic imbalance and increased reperfusion arrhythmias Am J Physiol Heart Circ Physiol, September 1, 2009; 297(3): H960 - H967. [Abstract] [Full Text] [PDF]

				G. L. Aistrup, R. Villuendas, J. Ng, A. Gilchrist, T. W. Lynch, D. Gordon, I. Cokic, S. Mottl, R. Zhou, D. A. Dean, et al. Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation Cardiovasc Res, August 1, 2009; 83(3): 481 - 492. [Abstract] [Full Text] [PDF]

				R. Arora, J. S. Ulphani, R. Villuendas, J. Ng, L. Harvey, S. Thordson, F. Inderyas, Y. Lu, D. Gordon, P. Denes, et al. Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atrium Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H134 - H144. [Abstract] [Full Text] [PDF]

				T. Miyamoto, T. Kawada, Y. Yanagiya, M. Inagaki, H. Takaki, M. Sugimachi, and K. Sunagawa Cardiac sympathetic nerve stimulation does not attenuate dynamic vagal control of heart rate via {alpha}-adrenergic mechanism Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H860 - H865. [Abstract] [Full Text] [PDF]